First patient treated with Leqembi® (lecanemab) in Sweden

BioArctic announced that Leqembi is now available at a private clinic in Sweden, with the first Swedish patient beginning treatment outside of a clinical-trial setting. The milestone expands real-world access to the Alzheimer's therapy in BioArctic's home market, though the announcement provides no revenue, pricing, or patient-volume details.